An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
In May 2013, nearly 20 years after the discovery that mutations on the BRCA1 and BRCA2 genes could lead to a higher risk of breast and ovarian cancer, A-list Hollywood actress Angelina Jolie garnered ...
HealthDay News — Only about one-third of women receive genetic counseling before they undergo testing for BRCA mutations, and patients who receive genetic counseling beforehand display better ...
Gila Pfeffer is a humor writer who splits her time between NYC and London. The following is an adapted excerpt from her memoir, "Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences." ...
FoundationOne Liquid CDx can be used to identify niraparib and abiraterone acetate eligibility in patients with metastatic castration-resistant prostate cancer (mCRPC). According to the American ...
Pathway Genomics said that it has launched BRCATrue, a next- generation sequencing and deletion/duplication analysis that can detect mutations in BRCA1 and BRCA2, the genes linked to breast, ovarian ...
“Being the first and only direct-to-consumer genetics company to receive FDA authorization to test for cancer risk without a prescription is a major milestone for 23andMe and for the consumer,” Anne ...
Celebrity health announcements may not motivate people who need testing the most to act, study finds
In a study published in The BMJ, researchers examined the effect the 2013 op-ed by actress Angelina Jolie had on BRCA testing. Ms. Jolie detailed her decision to undergo a preventative mastectomy ...
Add Yahoo as a preferred source to see more of our stories on Google. "Today" show contributor Jill Martin is opening up about her journey with breast cancer, which started last month when she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results